Skip to main content
Original article

Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina

Authors
  • Harun Hodžić (Cantonal Hospital, Zenica, Zenica, Department of Urology, Bosnia and Herzegovina)
  • Amel Bajramović (High Security Penitentiary Zenica, Zenica, Bosnia and Herzegovina)
  • Zarema Obradović (Institute for Public Health of Canton Sarajevo, Sarajevo, Bosnia and Herzegovina)
  • Mersiha Mahmić-Kaknjo (Cantonal Hospital, Zenica, Zenica, Department of Clinical Pharmacology, Bosnia and Herzegovina)

Abstract

Aim: To determine the prevalence of hepatitis C virus infection (HCV) among prisoners in Zenica prison, and to investigate the relation between HCV and risky behaviors: intravenous drugs use (IDU), tattooing, promiscuity.

Methods: This cross-sectional study conducted at the High Security Penitentiary in Zenica involved 200 convicted persons who gave their consents for the research. Their blood was tested by AraGen Hepatitis C Test. Risky behaviors (IDU, tattooing, promiscuity) were tested by an anonymous self-administered questionnaire.

Results: The prevalence of HCV was 13% (26/200). There was a statistically significant correlation of HCV infection and drug abuse before imprisonment (p=0.00), injection drug abuse before imprisonment (p=0.00), tattooing in prison (p=0.03) and having sex with homosexual partners (p=0.00).

Conclusion: The prevalence of HCV in prisoners at Zenica prison was significantly higher than in the general Bosnia and Herzegovina population. Intravenous drugs use had highest risk for HCV infection among prisoners.

Keywords: tattooing, homosexuality, substance abuse

How to Cite:

Hodžić, H., Bajramović, A., Obradović, Z. & Mahmić-Kaknjo, M., (2017) “Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina”, Medicinski glasnik 14(1), 73-78. doi: https://doi.org/10.17392/880-16

Downloads:
Download PDF
View PDF

0 Views

0 Downloads

Published on
2017-02-01

Peer Reviewed

License

CC-BY-NC-ND 4.0